Satisfaction of patients after treatment with botulinum toxin for dynamic facial lines.
OBJECTIVE
To gain first evidence on the patient satisfaction after treatment with botulinum toxin type A (BTX-A) and to check for differences in satisfaction with respect to clinical, psychologic, and sociodemographic parameters.


METHODS
In this pilot study, 30 patients who had been treated with BTX-A within the last 3 months answered a standardized questionnaire (the Freiburg questionnaire on aesthetic dermatology and cosmetic surgery). The items assessed were attitudes on beauty and body, satisfaction with treatment outcome, and general quality of life. A prospective study consisting of the same items runs parallel and will be published later.


RESULTS
More than 80% of the patients answered that the treatment had been beneficial to them. All patients would recommend treatment completely or mostly. Only a very small part of the patients was moderately stressed by the treatment.


CONCLUSIONS
Injections with BTX-A is a satisfying and well-tolerated treatment of dynamic facial lines for all patients in this pilot study.
Sommer
Boris
B
Rosenparkklinik Center for Aesthetic Dermatologic Surgery, Darmstadt, Germany. b.sommer@rosenparkklinik.de
Zschocke
Ina
I
Bergfeld
Dorothee
D
Sattler
Gerhard
G
Augustin
Matthias
M
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D005145:Face; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009122:Muscle Hypertonia / Q000188:drug therapy; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D017060:Patient Satisfaction; D010865:Pilot Projects; D015595:Skin Aging / Q000187:drug effects*; D011795:Surveys and Questionnaires
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A